How Will Integration of Kidney Stone Management Devices as an Outpatient Procedure Influence the Industry Landscape Global sales of kidney stone management devices are likely to surpass 1 million units by 2028, according to a new Fact.MR study. In terms of revenues, the study projects the kidney stone management devices market to surpass US$ 1,500 million. Rising preferences for minimally invasive and non-invasive surgical procedures continue to be a massive trend in the kidney stone management devices market. The growing incidence rate of kidney stones, combined with the availability of affordable minimally invasive treatment is likely to sustain demand for kidney stone management devices during the forecast period 20182028. The report opines that manufacturers will be hard-pressed to develop innovative devices for large stones, as it has remained a longstanding challenge for healthcare providers. For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=1827 According to the report, lithotripsy devices will continue to account for over 80% revenue share of the market. Lithotripsy devices have remained the go-to medical devices in urology and renal conditions, and their lucrativeness is likely to continue over the course of the forecast period. The report finds that nephroscopes are likely to witness impressive sales in the kidney stone management devices market, owing to their competency of offering high-definition images with optimized working conditions. Europe is the most lucrative market for kidney stone management devices market, and the status quo is likely to continue throughout the forecast period. Asia Pacific excluding Japan (APEJ) follows suit, and it is likely that the region will witness the proliferation of kidney stone management devices in the near future. The emergence of various Asian countries as a global medical tourism hub, and the steady improvement in access to healthcare are likely to induce a transformation in the Asia Pacific kidney stone management devices market. Hospitals will remain at the forefront of demand, with this end-use segment accounting for nearly half of the global revenue share. The rising prevalence of kidney stones and subsequent surge in the number of hospital admissions is a key factor supplementing this demand, according to the report. The study finds that kidney stone management device sales through hospitals will be complemented by sales through specialty clinics. As per the report, the specialty clinics are envisioned to expand at an impressive CAGR of 5.5% from 2018 to 2028.
How Will Integration of Kidney Stone Management Devices as an Outpatient Procedure Influence the Ind
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.